Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Chlorhexidine Versus Normal Saline Socket Irrigation for Prevention of Dry Socket After Lower Wisdom Tooth Extraction (CHX-AO)

Comparison of the Effect of Immediate Post-Extraction Socket Irrigation With Normal Saline Versus Chlorhexidine on the Frequency of Dry Socket: A Single-Blinded Randomized Controlled Trial

Dry socket, also called alveolar osteitis, is a painful complication that can occur after tooth extraction, particularly following removal of impacted lower wisdom teeth. It occurs when the blood clot that normally forms in the extraction socket is lost or breaks down, resulting in pain and delayed healing.

This study will compare two solutions used to irrigate the extraction socket immediately after removal of an impacted lower wisdom tooth: normal saline and chlorhexidine. The study will determine whether immediate socket irrigation with chlorhexidine reduces the frequency of dry socket compared with normal saline.

A total of 174 eligible patients undergoing surgical extraction of impacted lower wisdom teeth will be randomly assigned to receive either normal saline or chlorhexidine for immediate post-extraction socket irrigation. Participants will not be informed which irrigation solution they receive. The extraction will be performed by a single surgeon, and postoperative assessment will be performed by a co-researcher.

Participants will be assessed for signs and symptoms of dry socket on postoperative days 2, 3, and 5. The occurrence of dry socket will be determined using predefined clinical criteria, including pain, trismus, halitosis, gingival inflammation, exposed or bare bone, radiating pain, and ipsilateral lymphadenopathy.

The study will compare the frequency of dry socket between the chlorhexidine and normal saline groups. The findings may help determine whether chlorhexidine is more effective than normal saline for reducing the occurrence of dry socket after surgical extraction of impacted lower wisdom teeth.

Panoramica dello studio

Stato

Attivo, non reclutante

Condizioni

Intervento / Trattamento

Descrizione dettagliata

Alveolar osteitis, commonly known as dry socket, is a painful postoperative complication that may occur following tooth extraction. It is characterised by moderate to severe pain at the extraction site and may be associated with delayed healing and other local clinical signs. The condition generally develops within the first few days following extraction and may cause considerable discomfort to patients.

The development of alveolar osteitis has been associated with breakdown or loss of the blood clot within the extraction socket. Local fibrinolytic activity and bacterial factors have been proposed as contributing mechanisms. Surgical trauma, bacterial contamination and other patient- and procedure-related factors may increase the risk of alveolar osteitis.

Normal saline is commonly used for irrigation of extraction sockets after surgical tooth removal. Chlorhexidine has antimicrobial and antiseptic properties and has been investigated for its potential role in reducing the occurrence of alveolar osteitis. Previous studies have reported lower frequencies of dry socket following chlorhexidine use compared with saline or other postoperative measures. However, the effectiveness of immediate post-extraction socket irrigation with chlorhexidine compared with normal saline requires further evaluation in the local clinical setting.

This single-blinded randomized controlled trial will compare the effect of immediate post-extraction socket irrigation with chlorhexidine versus normal saline on the frequency of dry socket following surgical extraction of impacted lower wisdom teeth.

Eligible patients will be recruited from the Oral and Maxillofacial Surgery Department, CMH Medical College and Institute of Dentistry, Lahore. Participants will be adults aged 18-50 years who are classified as ASA physical status I or II and who require surgical extraction of impacted lower wisdom teeth with slight to moderate difficulty according to Pederson's scale.

After informed consent is obtained, eligible participants will be randomly allocated to one of two treatment groups using a lottery method. One group will receive immediate irrigation of the extraction socket with chlorhexidine, while the other group will receive immediate irrigation with normal saline. The allocated irrigation solution will be applied after completion of the tooth extraction and before closure of the extraction socket. The extraction procedure will be performed by a single surgeon under local anaesthesia.

Participants will remain unaware of the irrigation solution allocated to them. Postoperative assessment will be performed by a co-researcher to reduce the potential for assessment bias. Standard postoperative instructions and postoperative medications will be provided according to the study protocol.

Participants will be evaluated on postoperative days 2, 3, and 5 for clinical features of alveolar osteitis. Dry socket will be diagnosed when at least three predefined diagnostic criteria are present. The criteria include mild to severe pain, trismus, halitosis, an inflamed or hyperaemic gingival area, exposed or bare bone with an empty socket, radiating pain to the ear or temporal region, and ipsilateral lymphadenopathy.

Trismus will be assessed by measuring the maximum inter-incisal distance in millimetres. A value below 35 mm will be considered indicative of trismus.

The primary purpose of the study is to determine whether immediate post-extraction socket irrigation with chlorhexidine reduces the frequency of alveolar osteitis compared with normal saline. The findings may provide evidence regarding the effectiveness of chlorhexidine as an alternative to normal saline for immediate socket irrigation following surgical extraction of impacted lower wisdom teeth.

Tipo di studio

Interventistico

Iscrizione (Effettivo)

174

Fase

  • Non applicabile

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Luoghi di studio

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

  • Adulto

Accetta volontari sani

No

Descrizione

Inclusion Criteria:

  1. Adults aged 18 to 50 years.
  2. Patients requiring surgical extraction of an impacted lower third molar (lower wisdom tooth).
  3. Impacted lower third molars classified as having slight to moderate difficulty according to Pederson's scale.
  4. Patients classified as American Society of Anesthesiologists (ASA) physical status I or II.
  5. Patients of either biological sex.
  6. Patients who provide written informed consent to participate in the study.

Exclusion Criteria:

  1. Systolic blood pressure ≥160 mmHg.
  2. Diastolic blood pressure ≥100 mmHg.
  3. Current smokers.
  4. Alcohol use.
  5. Patients with muscular diseases.
  6. Patients currently taking antibiotics or anti-inflammatory medications.
  7. Patients with physical or mental disabilities that would prevent participation in the study or completion of follow-up assessments.
  8. Patients requiring extraction without bony osteotomy.
  9. Deep or very difficult impactions according to Pederson's scale.

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Prevenzione
  • Assegnazione: Randomizzato
  • Modello interventistico: Assegnazione parallela
  • Mascheramento: Doppio

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Sperimentale: Chlorhexidine Socket Irrigation
Participants allocated to the experimental group will undergo surgical extraction of an impacted lower third molar under local anaesthesia. Immediately after extraction, the extraction socket will be irrigated with chlorhexidine according to the study protocol, followed by socket closure with silk suture. Participants will receive the same postoperative instructions and medications as the comparator group. Postoperative assessment for alveolar osteitis will be performed on days 2, 3, and 5.
Immediate post-extraction irrigation of the surgical extraction socket with chlorhexidine following removal of an impacted lower third molar. The allocated chlorhexidine solution will be applied immediately after extraction and before socket closure with silk suture. The extraction will be performed under local anaesthesia by a single surgeon. The concentration and volume of chlorhexidine will be administered according to the study protocol.
Comparatore attivo: Normal Saline Socket Irrigation
Participants allocated to the comparator group will undergo surgical extraction of an impacted lower third molar under local anaesthesia. Immediately after extraction, the extraction socket will be irrigated with normal saline according to the study protocol, followed by socket closure with silk suture. Participants will receive the same postoperative instructions and medications as the experimental group. Postoperative assessment for alveolar osteitis will be performed on days 2, 3, and 5.
Immediate post-extraction irrigation of the surgical extraction socket with normal saline following removal of an impacted lower third molar. The allocated normal saline solution will be applied immediately after extraction and before socket closure with silk suture. The extraction will be performed under local anaesthesia by a single surgeon. The volume of normal saline will be administered according to the study protocol.

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Frequency of Alveolar Osteitis (Dry Socket)
Lasso di tempo: Postoperative days 2, 3, and 5
The frequency of alveolar osteitis (dry socket) will be assessed in participants following surgical extraction of an impacted lower third molar. Alveolar osteitis will be diagnosed when at least three predefined clinical criteria are present, including mild to severe postoperative pain, trismus, halitosis, inflamed or hyperaemic gingiva, exposed or bare bone with an empty socket, radiating pain to the ear or temporal region, and ipsilateral lymphadenopathy. The number and percentage of participants developing alveolar osteitis will be compared between the chlorhexidine and normal saline groups.
Postoperative days 2, 3, and 5

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Postoperative Trismus
Lasso di tempo: Postoperative days 2, 3, and 5
Trismus will be assessed by measuring the maximum inter-incisal distance in millimetres using a ruler. An inter-incisal distance of less than 35 mm will be considered indicative of trismus. Measurements will be compared between the chlorhexidine and normal saline groups.
Postoperative days 2, 3, and 5
Postoperative Pain Intensity
Lasso di tempo: Postoperative days 2, 3, and 5
Postoperative pain will be assessed using a Visual Analogue Scale (VAS). VAS is a 10 cm scale, the smaller the VAS Score, the pain is of low intensity and vice versa. Pain intensity will be recorded during postoperative assessment and compared between the chlorhexidine and normal saline groups.
Postoperative days 2, 3, and 5

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Sponsor

Investigatori

  • Cattedra di studio: Asad A Chatha, BDS, FCPS, CMH Lahore Medical College and Institute of Dentistry

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Effettivo)

14 febbraio 2026

Completamento primario (Stimato)

4 ottobre 2026

Completamento dello studio (Stimato)

28 ottobre 2026

Date di iscrizione allo studio

Primo inviato

5 settembre 2026

Primo inviato che soddisfa i criteri di controllo qualità

5 settembre 2026

Primo Inserito (Effettivo)

11 settembre 2026

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

14 settembre 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

10 settembre 2026

Ultimo verificato

1 settembre 2026

Maggiori informazioni

Termini relativi a questo studio

Termini MeSH pertinenti aggiuntivi

Altri numeri di identificazione dello studio

  • 228/ERC/CMH/LMC

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

NO

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .